We've finally slowed the surge in overdose deaths. The Trump admin may undo all of it

We've finally slowed the surge in overdose deaths. The Trump admin may undo all of it
Under Trump and RFK Jr., gutting key government agencies could make overdoses soar again

By Charles LeBaron
Author and former medical epidemiologist at the CDC
Published June 5, 2025 5:45AM (EDT)


(Salon) On May 14, 2025, the Division of Overdose Prevention at the Centers for Disease Control and Prevention announced that the number of overdose deaths in 2024 had dropped 27%. This was an extraordinary, even historic announcement, given overdoses had risen relentlessly for more than 33 years, resulting in the deaths of more than a million Americans, with another 1 million projected to die before this decade is over. Now, for more than a year, overdose deaths have decreased every single month, most dramatically for deaths caused by illicit fentanyl — considered the toughest problem, given the opioid’s high potency, simplicity of manufacture, and ease of smuggling.

That very same day, the new Secretary of Health and Human Services, Robert F. Kennedy Jr., in testimony before Congress, made no reference to overdoses, the number one killer of Americans 18 to 44 years of age, nor to the recent success. A week later, in his agency’s 72-page “Making America Healthy Again” manifesto, the word “opioid” was never mentioned. Instead, he went on to propose that CDC should be disassembled, along with the other principal agencies responsible for addressing the overdose crisis. Those proposals, as part of the administration’s 2026 fiscal year budget, passed the House and await action by the Senate.

For nearly thirty years I was a CDC scientist. I have been outspokenly critical of how CDC and those other agencies have handled the opioid crisis, but the solution is not to take a wrecking ball to the institutions that protect us, particularly when we seem to be making progress. What will be the consequences? A health secretary who systematically ignores mention of the major killer of adult Americans is clearly not interested in research on what could account for a decrease in deaths.

But among recent national initiatives, the push to increase availability of the opioid overdose antidote, naloxone (brand name Narcan), has clearly played a role. Between 2021 and 2023, the number of naloxone doses dispensed from retail pharmacies doubled, and millions of additional doses were distributed by harm reduction organizations. Then in March 2023, the Food and Drug Administration approved over-the-counter distribution of a nasal spray version. ..................(more)

https://www.salon.com/2025/06/05/weve-finally-slowed-the-surge-in-overdose-deaths-the-admin-may-undo-all-of-it/